Comparative Tumorigenicity and DNA Damage Induced by Dibenzo[ def,p]chrysene and Its Metabolites in the Mouse Ovary.

Ovarian cancer ranked second in incidence among gynecologic cancers, but it causes more deaths than any other gynecologic cancer; at present there is no curative treatment beyond surgery. Animal models that employ carcinogens found in the human environment can provide a realistic platform to understand the mechanistic basis for disease development and to design rational chemopreventive/therapeutic strategies. We and others have shown that the administration of the environmental pollutant and tobacco smoke constituent dibenzo[ def,p]chrysene (DBP) to mice by several routes of exposure can induce tumors in multiple sites including the ovary. In the present study we compared, for the first time, the tumorigenicity and DNA damage induced by DBP and its metabolites DBP-dihydrodiol (DBPDHD) and DBP-dihydrodiol epoxide (DBPDE) in the mouse ovary. Compounds were dissolved in dimethyl sulfoxide (DMSO) as the vehicle and administered by topical application into the mouse oral cavity three times per week for 38 weeks. No tumors were observed in mice treated with DMSO. At equal dose (24 nmol/30 μL DMSO), the incidence of ovarian tumors induced by DBPDHD was higher (60.7%), although not significantly, than that induced by DBP (44.8%). Similarly the levels of DNA damage induced by DBPDHD in the ovary were higher than those observed with DBP. We did not observe any histological abnormality in the ovary of mice treated with DBPDE, which is consistent with lack of DNA damage. Our results suggested that both DBP and DBPDHD can be metabolized in the mouse ovary leading to the formation of DBPDE that can damage DNA, which is a prerequisite step in the initiation stage of carcinogenesis.

[1]  T. Penning,et al.  Polycyclic Aromatic Hydrocarbons: Multiple Metabolic Pathways and the DNA Lesions Formed , 2010 .

[2]  S. Amin,et al.  Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases. , 2011, Chemical research in toxicology.

[3]  Elizabeth M. Kanter,et al.  Dual Modality Imaging of a Novel Rat Model of Ovarian Carcinogenesis , 2022 .

[4]  D. Warshawsky,et al.  Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. , 2005, Toxicology and applied pharmacology.

[5]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[6]  S. Amin,et al.  Tissue Distribution, Excretion and Pharmacokinetics of the Environmental Pollutant Dibenzo[def,p]chrysene in Mice. , 2015, Chemical research in toxicology.

[7]  Riqiang Bao,et al.  The molecular mechanism of ovarian granulosa cell tumors , 2018, Journal of Ovarian Research.

[8]  E. Cavalieri,et al.  Identification and quantitation of dibenzo[a,l]pyrene--DNA adducts formed by rat liver microsomes in vitro: preponderance of depurinating adducts. , 1995, Biochemistry.

[9]  F. Oesch,et al.  Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies. , 1998, Chemical research in toxicology.

[10]  S. Nesnow,et al.  Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. , 1997, Carcinogenesis.

[11]  S. Nesnow,et al.  Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts. , 1997, Carcinogenesis.

[12]  K. Ahn,et al.  Mutagenesis and carcinogenesis induced by dibenzo[a,l]pyrene in the mouse oral cavity: a potential new model for oral cancer , 2012, International journal of cancer.

[13]  A. Luch,et al.  The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7. , 1999, Carcinogenesis.

[14]  S. Amin,et al.  Induction of ovarian cancer and DNA adducts by Dibenzo[a,l]pyrene in the mouse. , 2012, Chemical research in toxicology.

[15]  S. Amin,et al.  Synthesis of Fjord region diol epoxides as potential ultimate carcinogens of dibenzo[a,l]pyrene. , 1994, Chemical research in toxicology.

[16]  C. Smith,et al.  Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Amin,et al.  A Highly Abbreviated Synthesis of Dibenzo[def,p]chrysene and Its 12-Methoxy Derivative, a Key Precursor for the Synthesis of the Proximate and Ultimate Carcinogens of Dibenzo[def,p]chrysene. , 2004, Journal of Organic Chemistry.

[18]  A. Luch,et al.  Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation. , 2002, Chemical research in toxicology.

[19]  S. Amin,et al.  Identification and quantification of DNA adducts in the oral tissues of mice treated with the environmental carcinogen dibenzo[a,l]pyrene by HPLC-MS/MS. , 2011, Chemical research in toxicology.

[20]  S. Amin,et al.  Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene. , 1995, Carcinogenesis.

[21]  A. Luch,et al.  Cancer initiation by polycyclic aromatic hydrocarbons results from formation of stable DNA adducts rather than apurinic sites. , 1999, Carcinogenesis.

[22]  R. Drapkin,et al.  Ovarian Cancer Pathogenesis: A Model in Evolution , 2009, Journal of oncology.

[23]  A. Dipple,et al.  DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. , 1998, Chemical research in toxicology.

[24]  S. Amin,et al.  Carcinogenesis of the Oral Cavity: Environmental Causes and Potential Prevention by Black Raspberry. , 2017, Chemical research in toxicology.

[25]  L. Puy,et al.  Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke. , 1998, Molecular human reproduction.

[26]  S. Amin,et al.  Mammary carcinogenicity in female CD rats of fjord region diol epoxides of benzo[c]phenanthrene, benzo[g]chrysene and dibenzo[a,l]pyrene. , 1995, Carcinogenesis.

[27]  E. Cavalieri,et al.  Identification and quantification of stable DNA adducts formed from dibenzo[a,l]pyrene or its metabolites in vitro and in mouse skin and rat mammary gland. , 2005, Chemical Research in Toxicology.

[28]  I. Treilleux,et al.  17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1. , 2015, Carcinogenesis.

[29]  N. Kerkvliet,et al.  Dibenzo[a,l]pyrene induced DNA adduct formation in lung tissue in vivo. , 2005, Cancer letters.

[30]  J. Barton,et al.  Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure. , 2009, Gynecologic Oncology.

[31]  A. Luch,et al.  Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. , 1995, Carcinogenesis.

[32]  S. Amin,et al.  Simultaneous Detection of Deoxyadenosine and Deoxyguanosine Adducts in the Tongue and Other Oral Tissues of Mice Treated with Dibenzo[a,l]pyrene , 2014, Chemical research in toxicology.

[33]  Melissa J. Davis,et al.  Nuclear Receptor Profiling of Ovarian Granulosa Cell Tumors , 2011, Hormones & cancer.

[34]  H. Dienes,et al.  Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol. , 2004, Chemico-biological interactions.

[35]  A. Luch,et al.  Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells. , 1999, Chemical Research in Toxicology.

[36]  Y. Fujii‐Kuriyama,et al.  Dibenzo[A,L]pyrene‐induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor‐deficient mice , 2004, International journal of cancer.

[37]  K. Ahn,et al.  Mechanisms of oral carcinogenesis induced by dibenzo[a,l]pyrene: An environmental pollutant and a tobacco smoke constituent , 2013, International journal of cancer.

[38]  L. Ehrenberg,et al.  Studies of dose distribution, premutagenic events and mutation frequencies for benzo[a]pyrene aiming at low dose cancer risk estimation. , 2001, Mutagenesis.

[39]  N. H. Velthorst,et al.  Direct Determination of Dibenzo[a,l]pyrene in Crude Extracts of Environmental Samples by Laser-Excited Shpol'skii Spectroscopy , 1995 .

[40]  Jean-François Ethier,et al.  Reproductive Biology and Endocrinology Open Access Animal Models of Ovarian Cancer , 2022 .